Haplotypes in the complement factor H (CFH) gene: Associations with drusen and advanced age-related macular degeneration

Peter J. Francis, Dennis W. Schultz, Sara Hamon, Jurg Ott, Richard Weleber, Michael Klein

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Background. Age-related macular degeneration (AMD), the leading cause of blindness in the Western world, is a complex disease that affects people over 50 years old. The complement factor H (CFH) gene has been repeatedly shown to be a major factor in determining susceptibility to the advanced form of the condition. We aimed to better understand the functional role of this gene in the AMD disease process and assess whether it is associated with earlier forms of the disease. Methodology/Principal Findings. We genotyped SNPs at the CFH gene locus in three independent populations with AMD: (a) extended families where at least 3 family members had AMD; (b) sporadic cases of advanced AMD and (c) cases from the Age-Related Eye Disease Study (AREDS). We investigated polymorphisms and haplotypes in and around the CFH gene to assess their role in AMD. CFH is associated with early/intermediate and advanced AMD in both familial and sporadic cases. In our populations, the CFH SNP, rs2274700, is most strongly associated with AMD and when incorporated into a haplotype with the Y402H SNP and rs1061147, the strongest association is observed (p-9). Conclusions/Significance. Our results, reproduced in three populations that represent the spectrum of AMD cases, provide evidence that the CFH gene is associated with drusen as well as with advanced AMD. We also identified novel susceptibility and protective haplotypes in the AMD populations.

Original languageEnglish (US)
Article numbere1197
JournalPLoS One
Volume2
Issue number11
DOIs
StatePublished - Nov 28 2007

Fingerprint

Complement Factor H
Macular Degeneration
Haplotypes
haplotypes
complement
Genes
genes
Single Nucleotide Polymorphism
Polymorphism
Population
macular degeneration
extended families
eye diseases
Western World
Eye Diseases
blindness
Blindness

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Haplotypes in the complement factor H (CFH) gene : Associations with drusen and advanced age-related macular degeneration. / Francis, Peter J.; Schultz, Dennis W.; Hamon, Sara; Ott, Jurg; Weleber, Richard; Klein, Michael.

In: PLoS One, Vol. 2, No. 11, e1197, 28.11.2007.

Research output: Contribution to journalArticle

@article{ae478e47cf8b474a9f05fc261551caa0,
title = "Haplotypes in the complement factor H (CFH) gene: Associations with drusen and advanced age-related macular degeneration",
abstract = "Background. Age-related macular degeneration (AMD), the leading cause of blindness in the Western world, is a complex disease that affects people over 50 years old. The complement factor H (CFH) gene has been repeatedly shown to be a major factor in determining susceptibility to the advanced form of the condition. We aimed to better understand the functional role of this gene in the AMD disease process and assess whether it is associated with earlier forms of the disease. Methodology/Principal Findings. We genotyped SNPs at the CFH gene locus in three independent populations with AMD: (a) extended families where at least 3 family members had AMD; (b) sporadic cases of advanced AMD and (c) cases from the Age-Related Eye Disease Study (AREDS). We investigated polymorphisms and haplotypes in and around the CFH gene to assess their role in AMD. CFH is associated with early/intermediate and advanced AMD in both familial and sporadic cases. In our populations, the CFH SNP, rs2274700, is most strongly associated with AMD and when incorporated into a haplotype with the Y402H SNP and rs1061147, the strongest association is observed (p-9). Conclusions/Significance. Our results, reproduced in three populations that represent the spectrum of AMD cases, provide evidence that the CFH gene is associated with drusen as well as with advanced AMD. We also identified novel susceptibility and protective haplotypes in the AMD populations.",
author = "Francis, {Peter J.} and Schultz, {Dennis W.} and Sara Hamon and Jurg Ott and Richard Weleber and Michael Klein",
year = "2007",
month = "11",
day = "28",
doi = "10.1371/journal.pone.0001197",
language = "English (US)",
volume = "2",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "11",

}

TY - JOUR

T1 - Haplotypes in the complement factor H (CFH) gene

T2 - Associations with drusen and advanced age-related macular degeneration

AU - Francis, Peter J.

AU - Schultz, Dennis W.

AU - Hamon, Sara

AU - Ott, Jurg

AU - Weleber, Richard

AU - Klein, Michael

PY - 2007/11/28

Y1 - 2007/11/28

N2 - Background. Age-related macular degeneration (AMD), the leading cause of blindness in the Western world, is a complex disease that affects people over 50 years old. The complement factor H (CFH) gene has been repeatedly shown to be a major factor in determining susceptibility to the advanced form of the condition. We aimed to better understand the functional role of this gene in the AMD disease process and assess whether it is associated with earlier forms of the disease. Methodology/Principal Findings. We genotyped SNPs at the CFH gene locus in three independent populations with AMD: (a) extended families where at least 3 family members had AMD; (b) sporadic cases of advanced AMD and (c) cases from the Age-Related Eye Disease Study (AREDS). We investigated polymorphisms and haplotypes in and around the CFH gene to assess their role in AMD. CFH is associated with early/intermediate and advanced AMD in both familial and sporadic cases. In our populations, the CFH SNP, rs2274700, is most strongly associated with AMD and when incorporated into a haplotype with the Y402H SNP and rs1061147, the strongest association is observed (p-9). Conclusions/Significance. Our results, reproduced in three populations that represent the spectrum of AMD cases, provide evidence that the CFH gene is associated with drusen as well as with advanced AMD. We also identified novel susceptibility and protective haplotypes in the AMD populations.

AB - Background. Age-related macular degeneration (AMD), the leading cause of blindness in the Western world, is a complex disease that affects people over 50 years old. The complement factor H (CFH) gene has been repeatedly shown to be a major factor in determining susceptibility to the advanced form of the condition. We aimed to better understand the functional role of this gene in the AMD disease process and assess whether it is associated with earlier forms of the disease. Methodology/Principal Findings. We genotyped SNPs at the CFH gene locus in three independent populations with AMD: (a) extended families where at least 3 family members had AMD; (b) sporadic cases of advanced AMD and (c) cases from the Age-Related Eye Disease Study (AREDS). We investigated polymorphisms and haplotypes in and around the CFH gene to assess their role in AMD. CFH is associated with early/intermediate and advanced AMD in both familial and sporadic cases. In our populations, the CFH SNP, rs2274700, is most strongly associated with AMD and when incorporated into a haplotype with the Y402H SNP and rs1061147, the strongest association is observed (p-9). Conclusions/Significance. Our results, reproduced in three populations that represent the spectrum of AMD cases, provide evidence that the CFH gene is associated with drusen as well as with advanced AMD. We also identified novel susceptibility and protective haplotypes in the AMD populations.

UR - http://www.scopus.com/inward/record.url?scp=43549091327&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43549091327&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0001197

DO - 10.1371/journal.pone.0001197

M3 - Article

C2 - 18043728

AN - SCOPUS:43549091327

VL - 2

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 11

M1 - e1197

ER -